Detalhe da pesquisa
1.
Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial.
Lancet
; 397(10269): 112-118, 2021 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33357465
2.
Ultra-Early and Short-Term Tranexamic Acid Treatment in Patients With Good- and Poor-Grade Aneurysmal Subarachnoid Hemorrhage.
Neurology
; 102(12): e209169, 2024 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38788175
3.
Safety and efficacy of active blood-pressure reduction to the recommended thresholds for intravenous thrombolysis in patients with acute ischaemic stroke in the Netherlands (TRUTH): a prospective, observational, cluster-based, parallel-group study.
Lancet Neurol
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763149
4.
Tranexamic Acid After Aneurysmal Subarachnoid Hemorrhage: Post-Hoc Analysis of the ULTRA Trial.
Neurology
; 2022 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36266046
5.
Pre- and Interhospital Workflow Times for Patients With Large Vessel Occlusion Stroke Transferred for Endovasvular Thrombectomy.
Front Neurol
; 12: 730250, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34512538
6.
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.
Lancet Neurol
; 20(4): 275-283, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743237